Skip to main content

Advertisement

SpringerLink
Log in

Variability in the Efficacy of Psychopharmaceuticals: Contributions from Pharmacogenomics, Ethnopsychopharmacology, and Psychological and Psychiatric Anthropologies

  • Original Paper
  • Published:
Culture, Medicine, and Psychiatry Aims and scope Submit manuscript

Abstract

Psychological and psychiatric anthropology have long questioned the universality of psychiatric diagnoses, bringing to light the fluidity of mental disorder, and recognizing that the experience and expression of psychopathology is influenced by complex and interacting genetic, environmental, and cultural factors. The majority of our discussions, however, have remained centered around the role of culture in shaping mental illness: drawing attention to subjective experiences of mental illness and culturally patterned modes of symptom presentation, and interrogating the cogency of universal diagnostic rubrics. Psychological and psychiatric anthropology have yet to robustly engage the broadly assumed universal validity of psychiatric medications and the ways in which they are prescribed and experienced. This article provides an introduction into the fields of pharmacogenomics and ethnopsychopharmacology, areas of inquiry seeking to understand the ways in which genetic variability occurring between, and within, large population groups influences individual ability to metabolize psychotropic medications. This piece further addresses the complex issue of psychopharmaceutical efficacy, stressing the ways in which, just as with psychopathology, medications and their outcomes are likewise influenced by the complex interactions of genes, environment, and culture. Lastly, ways in which anthropology can and should engage with the growing fields of pharmacogenomics and ethnopsychopharmacology are suggested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arranz, Maria J., and Shitij Kapur 2008 Pharmacogenomics in Psychiatry: Are We Ready for Widespread Clinical Use? Schizophrenia Bulletin 34(6):1130-1144.

    Article  Google Scholar 

  • Bachmann, Christian J., Michael Haberhausen, Monika Heinzel-Gutenbrunner, Helmut Remschmidt, and Frank M. Theisen 2008 Large Intraindividual Variability of Olanzapine Serum Concentrations in Adolescent Patients. Therapeutic Drug Monitoring 30(1):108-112.

    Article  Google Scholar 

  • Bamshad, Michael, Stephen Wooding, Benjamin A. Salisbury, and J. Claiborne Stephens 2004 Deconstructing the Relationship Between Genetics and Race. Nature Review Genetics 5(8):598-609.

    Article  Google Scholar 

  • Biehl, Joao, Byron Good, and Arthur Kleinman 2007 Introduction: Rethinking Subjectivity. In Subjectivity: Ethnographic Investigations. Joao Biehl, Byron Good and Arthur Kleinman, eds. Pp. 1-23. Berkeley, CA: University of California Press.

    Google Scholar 

  • Bishop, Jeffrey, and Sharon Chae 2010 Should You Order Genetic Testing to Identify How Patients Metabolize Antipsychotics? Current Psychiatry 9(9):32-35.

    Google Scholar 

  • Bonham, Vence. L., Esther Warshauer-Baker, and Francis Collins 2005 Race and Ethnicity in the Genome Era: The Complexity of the Constructs. American Psychologist 60(1):9-15.

    Article  Google Scholar 

  • de Leon, Jose, Maria Arranz, and Gualberto Ruano 2008 Pharmacogenetic Testing in Psychiatry: A Review of Features and Clinical Realities. Clinics in Laboratory Medicine 28(4):599-617.

    Article  Google Scholar 

  • de Leon, Jose, Scott C. Armstrong, and Kelly L. Cozza 2006 Clinical Guidelines for Psychiatrists for the Use of Pharmacogenetic Testing for CYP450 2D6 and CYP450 2C19. Psychosomatics 47(1):75-85.

    Article  Google Scholar 

  • Delvecchio Good, Mary-Jo. 2007 The Medical Imaginary and the Biotechnical Embrace: Subjective Experiences of Clinical Science and Patients.” In Subjectivity: Ethnographic Investigations, by Joao Biehl, Byron Good and Arthur Kleinman, 382-380. Berkeley, CA: University of California Press.

    Google Scholar 

  • Dunbar, Lucy, Rachael Butler, Amanda Wheeler, Justin Pulford, Wayne Miles, and Janie Sheridan 2009 Clinician Experience in Employing the AmpliChip CYP450 Test in Routine Clinical Practice. Journal of Psychopharmacology 0(00):1-8.

    Google Scholar 

  • Eichelbaum, Michel, Magnus Ingelman-Sundberg, and William E. Evans 2006 Pharmacogenomics and Individualized Drug Therapy. Annual Review of Medicine 57:119-137.

    Article  Google Scholar 

  • Flores, Deborah L., and Ricardo Mendoza 2008 Variation in Psychotropic Responses in the Hispanic Population. In Ethno- psychopharmacology: Advances in current practice, by Chee H. Ng, Keh-Ming Lin, Bruce S. Singh and Edmond Chiu, 97-110. Cambridge: Cambridge University Press.

    Chapter  Google Scholar 

  • Fox Keller, Evelyn. 2007 Whole Bodies, Whole Persons? Cultural Studies, Psychoanalysis, and Biology. In Subjectivity: Ethnographic Investigations, by Joao Biehl, Byron Good and Arthur Kleinman, 352-361. Berkeley, CA: University of California Press.

    Google Scholar 

  • Gaines, Atwood D. 2008 Race: Local Biology and Cultures in Mind.” In A Companion to Psychological Anthropology: Modernity and Psychocultural Change, by Conerly Casey and Robert B. Edgerton, 274-297. Malden, MA: Wiley-Blackwell, 2008.

    Google Scholar 

  • Gartlehner, Gerald, Richard A. Hansen, Patricia Thieda, Angela M. DeVeaugh-Geiss, Bradley N. Gaynes, Erin E. Krebs, Linda J. Lux, Laura C. Morgan, Janelle A. Shumate, Loraine G. Monroe, and Kathleen N. Lohr 2007 Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression. Rockville, MD: Agency for Healthcare Research and Quality.

    Google Scholar 

  • Goff, Donald C., and Lisa Dixon 2011 Antipsychotic Polypharmacy: Are Two Ever Better Than One? American Journal of Psychiatry 168(7):667-669.

    Article  Google Scholar 

  • Hall-Flavin, Daniel K., Terry D. Schneekloth, and Josiah D. Allen 2010 Translational Psychiatry: Bringing Pharmacogenomic Testing into Clinical Practice. Psychiatry Weekly 5(13):39-44.

    Google Scholar 

  • Hardon, Anita 1992 That Drug is Hiyang For Me: Lay Perceptions in the Efficacy of Drugs in Manila, Philippines. Central Issues in Anthropology 10(1):86-93

    Article  Google Scholar 

  • Hunt, Linda M., and Mary S. Megyesi 2008 Genes, Race, and Research Ethics: Who’s Minding the Store? Journal of Medical Ethics 34(6):495-500.

    Article  Google Scholar 

  • Jenkins, Janis H. 2010 Introduction. In The Pharmaceutical Self: The Global Shaping of Experience in an Age of Psychopharmacology. Janis H. Jenkins, ed. Pp. 5-16. Sante Fe, NM: School of Advanced Research Press.

    Google Scholar 

  • Jones, David S., and Roy H. Perlis 2006 Pharmacogenomics, Race, and Psychiatry: Prospects and Challenges. Harvard Review of Psychiatry 14(2):92-108.

    Article  Google Scholar 

  • Kennedy, Jae. 2005 Herb and Supplement Use in the U.S. Adult Population. Clinical Therapeutics 27(11): 1847–1858.

  • Kirchheiner, Julia, Angela Seeringer, Roberto Viviani, and Steve Hodgkinson 2010 One Tablet or Two? Towards the Development of Pharmacogenomically Informed Drug Dose Individualization. In Pharmacogenomics in Psychiatry. M. Schwab, W.P. Kaschka and E. Spina, eds. Pp. 1-11. Basel, Switzerland: Karger.

    Chapter  Google Scholar 

  • Kleinman, Arthur, and Erin Fitz-Henry. 2007 The Experimental Basis of Subjectivity: How Individuals Change in the Context of Societal Transformation.” In Subjectivity: Ethnographic Investigations. Joao Biehl, Byron Good and Arthur Kleinman, eds., pp. 52–65. Berkeley, CA: University of California Press.

  • Knerr, Sarah, Edward Ramos, Juleigh Nowinski, Keianna Dixon, and Vence L. Bonham 2010 Human Difference in the Genomic Era: Facilitating a Socially Responsible Dialogue. Medical Genomics 3(1):1–6.

  • Koenig, Barbara A., Sandra Soo-Jin Lee, and Sarah S. Richardson 2008 Introduction: Race and Genetics in a Genomic Age. In Revisiting Race in a Genomic Age. Barbara A. Koenig, Sandra Soo-Jin Lee and Sarah S. Richardson, eds. Pp. 1-20. New Brunswick: Rutgers University Press.

    Google Scholar 

  • Lakoff, A. 2005 Pharmaceutical Reason: Knowledge and Value in Global Psychiatry. Cambridge: Cambridge University Press, 2005.

    Google Scholar 

  • Lambert, Timothy, and Trevor Norman 2008 Ethnic Differences in Psychotropic Drug Response and Pharmacokinetics. In Ethno- psychopharmacology: Advances in Current Practice. Chee H. Ng, Keh-Ming Lin, Bruce S. Singh and Edmond Chiu, eds. Pp. 38-61. Cambridge: Cambridge University Press.

    Chapter  Google Scholar 

  • Lawson, William B 2008 Identifying Inter-Ethnic Variations in Psychotropic Response in African American and Other Ethnic Minorities. In Ethno-psychopharmacology: Advances in Current Practice. Chee H. Ng, Keh-Ming Lin, Bruce S. Singh and Edmond Chiu, eds. Pp. 111-117. Cambridge: Cambridge University Press.

    Chapter  Google Scholar 

  • Lee, Min-Soo, Rhee-Hun Kang, and Sang-Woo Hahn 2008 Pharmacogenetics of Ethnic Populations.” In Ethno-psychopharmacology: Advances in Current Practice. Chee H. Ng, Lin Keh-Ming, Bruce, S. Singh and Edmond Chiu, eds. Pp. 27-37. Cambridge: Cambridge University Press.

    Google Scholar 

  • Lee, Sandra Soo-Jin 2003 Race, Distributive Justice and the Promise of Pharmacogenomics: Ethnical Considerations. American Journal of Pharmacogenomics 3(6):385-392.

    Article  Google Scholar 

  • Lee, Sing 1993 Side Effects of Chronic Lithium Therapy in Hong Kong Chinese: An Ethnopsychiatric Perspective. Culture, Medicine and Psychiatry 17(3): 301–320.

    Google Scholar 

  • Lee, Sing, Y.K. Wing, and K.C. Wong. 1992 Knowledge and Compliance Toward Lithium Therapy Among Chinese Psychiatric Patients in Hong Kong. Australian and New Zealand Journal of Psychiatry 26(3): 444–449.

  • Lieberman, Jeffrey A., et al. 2005 Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. The New England Journal of Medicine 353(12):1209-1233.

    Article  Google Scholar 

  • Lin, Keh-Ming 2010 Cultural and Ethnic Issues in Psychopharmacology: Addressing Both Instrumental and Symbolic Effects of Treatment. Psychiatric Times 27(1).

  • Lin, Keh-Ming, Chia-Hui Chen, Shu-Han Yu, and Sheng-Chang Wang 2008 Culture and Ethnicity in Psychopharmacology. In Ethno-psychopharmacology. Chee H. Ng, Keh-Ming Lin, Bruce S. Singh and Edmond Chiu, 27-37. Cambridge: Cambridge University Press, 2008.

    Chapter  Google Scholar 

  • Lusky, Karen 2006 Chip Shot: Psychiatry Puts Targeted Test in Play. College of American Pathologists. http://www.cap.org/apps/cap.portal, accessed February 15, 2011.

  • Maj, Mario 2008 Forward. In Ethno-psychopharmacology: Advances in Current Practice. Chee H. Ng, Keh-Ming Lin, Bruce S. Singh and Edmond Chiu, eds. Pp. xiii-xiv. Cambridge: Cambridge University Press.

    Google Scholar 

  • Malhotra, AK. 2001 Pharmacogenomics and Schizophrenia: Clinical Implications. The Pharmacogenomics Journal 1(1):109-114.

    Article  Google Scholar 

  • Marks, Jonathan 2008 Race: Past, Present, and Future. In Revisiting Race in a Genomic Age. Barbara A. Koenig, Sandra Soo-Jin Lee and Sarah S. Richardson, eds. Pp. 21-38. New Brunswick, NJ: Rutgers University Press.

    Google Scholar 

  • Moerman, Daniel. 2002 Meaning, Medicine, and the ‘Placebo Effect’. Cambridge: Cambridge University Press.

  • Morley, Katherine I., and Wayne D. Hall 2004 Using Pharmacogenetics and Pharmacogenomics in the Treatment of Psychiatric Disorders: some Ethical and Economic Considerations. Journal of Molecular Medicine 82(1):21-30.

    Article  Google Scholar 

  • Mrazek, David A. 2006 Psychiatric Pharmacogenomics. Focus IV (3):339-343.

    Google Scholar 

  • Mrazek, David A. 2010 Psychiatric Pharmacogenomics. Oxford: Oxford University Press.

    Google Scholar 

  • Ng, Chee H., and Steven Klimidis 2008 Cultural Factors and the Use of Psychotropic Medications. In Ethno- psychopharmacology: Advances in Clinical Practice, by Chee H. Ng, Keh-Ming Lin, Bruce S. Singh and Edmond Chiu, 123-134. Cambridge: Cambridge University Press.

    Chapter  Google Scholar 

  • Payne, Perry W. 2008 For Asians Only? The Perils of Ancestry-Based Drug Prescribing. Journal of Law, Medicine and Ethics 36(3):585-588.

    Article  Google Scholar 

  • Perlis, Roy H., David A. Ganz, Jerry Avorn, Sebastian Schneeweiss, Robert J. Glynn, Jordan W. Smoller, and Philip S. Wang 2005 Pharmacogenetic Testing and the Clinical Management of Schizophrenia. Journal of Clinical Psychopharmacology 25(5):427-435.

    Article  Google Scholar 

  • Picklar, David, and Katya Rubinow 2001 Pharmacogenomics of Psychiatric Disorders. TRENDS in Pharmacological Sciences 22(2):75-83.

    Article  Google Scholar 

  • Preskorn, Sheldon H. 2006 Pharmacogenomics, Informatics, and Individual Drug Therapy in Psychiatry: Past, Present and Future. Journal of Psychopharmacology 20(4):84-94.

    Article  Google Scholar 

  • Reeder, C.E., and W. Michael Dickson 2003 Economic Implications of Pharmacogenomics. In Pharmacogenomics: Social, Ethical, and Clinical Dimensions. Mark A. Rothstein, ed. Pp. 229-250. Hoboken, New Jersey: John Wiley & Sons, Inc.

    Google Scholar 

  • Rose, Nikolas. 2007 Social and Ethical Aspects of Pharmacogenomics in Psychiatry. Psychiatry 6(2): 80–82.

    Google Scholar 

  • Roses, Allen D 2004 Pharmacogenetics and Drug Development: The Path to Safer and More Effective Drugs. Nature Reviews Genetics 5:645-656.

    Article  Google Scholar 

  • Sajatovic, Martha, and Matthew A. Fuller 2008 Psychopharmacology and Culture. In Diversity Issues in the Diagnosis, Treatment, and Research of Mood Disorders. Sana Loue and Martha Sajatovic, eds. Pp. 215-230. Oxford: Oxford University Press.

    Google Scholar 

  • Schweitzer, Isaac 2008 Introduction. In Ethno-psychopharmacology: Advances in Current Practice. Chee H. Ng, Keh-Ming Lin, Bruce S. Singh and Edmond Chiu, eds. Pp. 1-4. Cambridge: Cambridge University Press.

    Chapter  Google Scholar 

  • Tate, Sarah K., and David B. Goldstein 2008 Will Tomorrow’s Medicines Work for Everyone? In Revisiting Race in a Genomic Era. Barbara A. Koenig, Sandra Soo-Jin Lee and Sarah S. Richardson, eds. Pp. 102-128. New Brunswick, NJ: Rutgers University Press.

    Google Scholar 

  • Wang, Vivian Ota, and Stanley Sue 2005 In the Eye of the Storm: Race and Genomics in Research and Practice. American Psychologist 60(1): 37-45.

    Article  Google Scholar 

  • Whyte, S.R., S. van der Geest, and A. Hardon. 2002 Social Lives of Medicines. Cambridge: University Press, Cambridge.

    Google Scholar 

  • Yu, Xin. 2008 Complementary Medicines in Mental Disorders. In Ethno-psychopharmacology: Advances in Clinical Practice. Chee H. Ng, Keh-Ming Lin, Bruce S. Singh and Edmond Chiu, eds., pp. 188–122. Cambridge: Cambridge University Press.

  • Zandi, Peter P., and Jennifer T. Judy 2010 The Promise and Reality of Pharmacogenomics in Psychiatry. Clinics in Laboratory Medicine 30(4):931-974.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Case Western Reserve University, Cleveland, OH, USA

    Kristi M. Ninnemann

Authors
  1. Kristi M. Ninnemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristi M. Ninnemann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ninnemann, K.M. Variability in the Efficacy of Psychopharmaceuticals: Contributions from Pharmacogenomics, Ethnopsychopharmacology, and Psychological and Psychiatric Anthropologies. Cult Med Psychiatry 36, 10–25 (2012). https://doi.org/10.1007/s11013-011-9242-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11013-011-9242-y

Keywords

Search

Navigation